Skip to main content
. 2019 Jan-Feb;9(1):10–20.

Table 1.

Characteristics of studies included in this meta-analysis

First Author and year Country Study population sex dose (g/day) Duration (week) Sample size Mean age Study design Jadad score Results
Japan healthy subjects M 5.6 1 15 58 p 3 SBP and DBP did not change significantly
USA healthy subjects F 6 8 23 58 p 3 SBP and DBP decreased significantly
Figueroa et al. 2009 USA healthy subjects M 6 4 17 22 c 3 SBP and DBP did not change at rest after intervention
Figueroa et al. 2009 USA healthy subjects M 6 4 17 22 c 3 SBP decreased significantly but DBP not changed significantly during CPT after intervention
Wong et al. 2015* USA healthy subjects F 6 8 27/41 58 p 3 SBP and DBP decreased significantly
USA healthy subjects F 6 2 13 70 c 4 SBP and DBP did not change significantly.
USA healthy subjects M 6 2 12 71 c 4 SBP did not change significantly. DBP decreased significantly
Israel healthy subjects M 6 2 16 24 c 4 SBP and DBP did not change significantly
USA healthy subjects M 9 2 16 23 c 2 SBP and DBP decreased significantly
Munoz et al. 2012 Mexico Heart Failure M/F 3 17 34 67 p 2 SBP and DBP did not change significantly

SBP, systolic blood pressure; DBP, diastolic blood pressure, M: male, F: female, P: Parallel, C: crossover

*

Data of the two groups from three groups of the study by Wong et.al. 2015 were used for analysis. The total number of patients were 4 but 27 were analyzed.